Health
New target for drug development could fill a major gap in depression treatment – News-Medical.net – Burnie Online News
Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects.
THE IDEAVanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression.The research was led by Lisa Monteggia,……
Continue Reading
-
Noosa News23 hours agoData shows 73 serving and former Australian Defence Force members died by suicide in 2023
-
Noosa News23 hours agoAustralian-funded PALM scheme liaison workers say they went months without pay
-
Noosa News24 hours agoBidding for a good cause
-
Noosa News23 hours agoMurray Watt slams Queensland LNP renewable energy policy